[HTML][HTML] High output heart failure in multiple myeloma: pathogenetic considerations
Simple Summary Multiple myeloma is a plasma cell disorder that accounts for around 10%
of all haematological malignancies. This neoplasia is often associated with a significant …
of all haematological malignancies. This neoplasia is often associated with a significant …
[HTML][HTML] High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
M Carlisi, S Mancuso, RL Presti, S Siragusa, G Caimi - Cancers, 2022 - ncbi.nlm.nih.gov
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
[PDF][PDF] High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations. Cancers 2022, 14, 610
M Carlisi, S Mancuso, R Lo Presti, S Siragusa, G Caimi - 2022 - iris.unipa.it
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
[PDF][PDF] High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations. Cancers 2022, 14, 610
M Carlisi, S Mancuso, R Lo Presti, S Siragusa, G Caimi - 2022 - pdfs.semanticscholar.org
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.
M Carlisi, S Mancuso, L Presti, S Siragusa, G Caimi - Cancers, 2022 - europepmc.org
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
M Carlisi, S Mancuso, RL Presti, S Siragusa… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
M Carlisi, S Mancuso, RL Presti, S Siragusa… - Cancers, 2022 - search.proquest.com
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …
[引用][C] High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
M Carlisi, S Mancuso, R Lo Presti, S Siragusa, G Caimi - CANCERS, 2022 - iris.unipa.it
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione Riviste Serie …
Home Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione Riviste Serie …
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.
M Carlisi, S Mancuso, L Presti, S Siragusa, G Caimi - Cancers, 2022 - europepmc.org
The high output heart failure is a clinical condition in which the systemic congestion is
associated to a high output state, and it can be observed in a non-negligible percentage of …
associated to a high output state, and it can be observed in a non-negligible percentage of …